Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 5 results when searching "Certolizumab pegol"

FORMULARY DECISION

Certolizumab pegol : Cimzia

TA375 (SMC 590/09) : Moderate to severe active rheumatoid arthritis in adult patients.

FORMULARY DECISION

Certolizumab pegol : Cimzia

TA383 (SMC 960/14) : For the treatment of adult patients with severe active axial spondyloarthritis.

FORMULARY DECISION

TA445 (SMC 973/14) : In combination with methotrexate, for the treatment of active psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug (DMARD) therapy has ...

FORMULARY DECISION

Certolizumab pegol : Cimzia

1155/16 : Treatment of severe, active and progressive RA in adults not previously treated with MTX or other DMARDs.

FORMULARY DECISION

Certolizumab pegol : Cimzia

SMC2132 : Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy